image
Altamira Therapeutics Ltd. CYTO
Healthcare - Biotechnology - NASDAQ - BM
Watchlist
$ 0.4554
5.91 %
$ 1.72 M
Market Cap
0.25
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 10.41%
10Years 0.00%
-5.92 M OPERATING INCOME
77.36%
Growth Rates
1Year 77.36%
3Years -3.84%
5Years 11.59%
7Years 20.78%
10Years 8.65%
-3.87 M NET INCOME
85.41%
Growth Rates
1Year 85.41%
3Years 22.15%
5Years 19.57%
7Years 25.60%
10Years 12.67%
EFFICIENCY
Earnings Waterfall Altamira Therapeutics Ltd.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 6.54 M
Operating Income -5.92 M
Other Expenses -2.05 M
Net Income -3.87 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0.3 63.9 K 0.2 56 K 1.3 0.3 (0.4) 67 K 3.0 0 0
GROSS PROFIT
Cost Of Revenue 0 1.4 2.2 0 0 0 0 0 0 0 0 0
Gross Profit 0 (1.1) (2.2) 0.2 56 K 1.3 0.3 (0.4) 67 K 3.0 0 0
OPERATING INCOME
Operating Expenses 6.5 25.0 14.9 5.5 7.3 11.0 24.4 30.2 30.9 22.2 14.6 4.6
Selling, General and Administrative Expenses 3.1 5.9 6.4 2.6 3.9 4.3 5.2 5.4 4.3 4.5 1.3 0.6
Research and Development Expenses 3.0 19.7 8.9 2.9 3.3 6.7 19.2 24.8 26.5 17.7 13.3 4.0
Operating Income (5.9) (26.1) (17.1) (5.3) (7.3) (11.0) (24.4) (30.2) (30.9) (22.2) (14.6) (4.6)
PRE-TAX INCOME
Interest Income Expense 0 0.9 0.2 0.1 28.6 K 1.1 1.6 0.8 8 K 49.6 K 50.2 K 0
Total Other Income (1.4) (0.6) (1.5) (2.9) 0.4 (0.4) 66 K (0.6) 1.2 4.0 82.9 K 8.09 K
Pre-Tax Income (7.3) (26.5) (17.4) (8.2) (6.8) (11.3) (24.4) (30.8) (29.7) (18.2) (14.7) (4.6)
NET INCOME
Tax Provision 0 10.3 K 21.6 K 21.3 K (0.2) 0.2 17.8 K (0.1) 84.8 K (0.9) 0.3 0
Net Income (7.3) (26.5) (17.4) (8.2) (6.6) (11.5) (24.4) (30.7) (29.7) (18.2) (15.0) (4.6)
EPS 14.8 583 525 545 456 2.89 K 22.3 K 35.7 K 36.8 K 26.3 K 33.2 K 10.2 K